United States · FDA National Drug Code directory
YUPELRI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49502-806_b7b789a7-deb0-41d7-9c7d-e6cf68d1b893
- Product NDC
- 49502-806
- Form
- SOLUTION
- Composition / generic term
- revefenacin
- Labeler
- Viatris Specialty LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181203
- Source listing expiry
- 20261231
Source-listed ingredients
- REVEFENACIN — 175 ug/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 7 POUCH in 1 CARTON (49502-806-87) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-33) / 3 mL in 1 VIAL, SINGLE-DOSE · 49502-806-87
- 30 POUCH in 1 CARTON (49502-806-93) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-32) / 3 mL in 1 VIAL, SINGLE-DOSE · 49502-806-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →